Key points are not available for this paper at this time.
Complex substances such as multiconstituent substances and substances of unknown or variable composition, complex reaction products, and biological materials (UVCBs) usually result from industrial processing, extraction of natural substances, or chemical reactions. Because of the variable and complex nature of source materials and the potential variability inherent to production processes, these substances can contain many, sometimes uncharacterized, constituents whose concentrations may vary between production batches. These UVCBs make up ∼20%-25% of substances registered under regulatory frameworks globally. To identify and advance the various challenges associated with UVCB testing and assessment, the Health and Environmental Sciences Institute (HESI) organized the international workshop "Exploring the Complexities of UVCB Testing and Risk Assessment." The HESI UVCB workshop was aimed at initiating multisectoral tripartite discussions on the advantages and disadvantages of whole substance versus representative constituent testing and assessment approaches, identifying further research needs, and establishing potential consensus for solutions for UVCB environmental risk assessment. Ultimately, the insight from the workshop contributed to the further refinement and strengthening of the exposure-centric tiered approach developed previously for consideration in the environmental risk assessment of UVCBs and multiconstituent substances. More specifically, it contributed to developing a systematic process to efficiently balance the characterization and testing of the whole substance and representative constituents to ensure the assessment of UVCBs is fit for purpose.
Déglin et al. (Wed,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: